National Health Investors, Inc. (NYSE:NHI) will post its quarterly earnings results before the market opens on Monday, November 6th. Analysts expect National Health Investors to post earnings of $0.92 per share for the quarter. National Health Investors has set its FY17 guidance at $5.22-5.26 EPS.

National Health Investors (NYSE:NHI) last announced its quarterly earnings results on Wednesday, August 9th. The real estate investment trust reported $0.93 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.29 by ($0.36). The company had revenue of $69.84 million during the quarter, compared to the consensus estimate of $67.68 million. National Health Investors had a return on equity of 12.56% and a net margin of 59.24%. The company’s revenue for the quarter was up 14.1% on a year-over-year basis. During the same period last year, the business posted $1.22 EPS. On average, analysts expect National Health Investors to post $5 EPS for the current fiscal year and $5 EPS for the next fiscal year.

Shares of National Health Investors, Inc. (NHI) opened at $78.07 on Friday. The company has a quick ratio of 12.45, a current ratio of 12.45 and a debt-to-equity ratio of 0.89. The firm has a market capitalization of $3.18 billion, a PE ratio of 15.29, a P/E/G ratio of 3.83 and a beta of 0.58.

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 10th. Stockholders of record on Friday, September 29th will be given a dividend of $0.95 per share. This represents a $3.80 annualized dividend and a dividend yield of 4.87%. The ex-dividend date of this dividend is Thursday, September 28th. National Health Investors’s payout ratio is presently 97.69%.

COPYRIGHT VIOLATION NOTICE: This piece was originally published by Watch List News and is the property of of Watch List News. If you are reading this piece on another publication, it was copied illegally and republished in violation of U.S. & international copyright & trademark laws. The correct version of this piece can be viewed at

A number of equities research analysts have issued reports on the stock. Zacks Investment Research downgraded shares of National Health Investors from a “buy” rating to a “hold” rating in a research report on Wednesday, September 6th. KeyCorp reaffirmed a “hold” rating on shares of National Health Investors in a research report on Sunday, September 17th. BidaskClub raised shares of National Health Investors from a “sell” rating to a “hold” rating in a research report on Thursday, August 17th. Finally, Capital One Financial Corporation started coverage on shares of National Health Investors in a research report on Monday, October 23rd. They set an “equal weight” rating for the company. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and one has assigned a buy rating to the company. The stock currently has an average rating of “Hold” and a consensus price target of $80.14.

In other National Health Investors news, insider Kevin Carlton Pascoe sold 2,000 shares of the stock in a transaction that occurred on Thursday, August 24th. The shares were sold at an average price of $79.80, for a total value of $159,600.00. Following the sale, the insider now directly owns 21,228 shares in the company, valued at approximately $1,693,994.40. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 5.19% of the company’s stock.

About National Health Investors

National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.

Earnings History for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.